a. Identify current initiatives, guidelines, activities, best practices and opportunities for collaborations related to the absence of inclusion and consideration of ethnic minority- issues in medical device development, including clinical research, design or other product activities;
b. Strategies to address cultural implications, bias and other issues in optimizing processes such as the identification of product development targets and disease states, engineering, design, and development risk management and other activities;
c. Strategies for minimizing unconscious bias or other forms of bias in recruitment, informed consent and retention of investigators and participants;
d. Identifying and characterizing clinical outcomes and needs of minority populations in defining research priorities; and
e. Targeting specific trial design enhancements to foster greater inclusion of minority researchers and patients, and raise awareness of issues that may affect this population.
kendalkwhitlock2@gmail.com
maithili.jha@ama-assn.org
meredith.barrett@resmed.com
nmarshall@evidation.com
ahong5@its.jnj.com
rachel@dimesociety.org
aftin.ross@fda.hhs.gov
Jaime_Wheeler@edwards.com
sonia.houston_pichardo@boehringer-ingelheim.com
Michelle.Tarver@fda.hhs.gov
Richardae.Araojo@fda.hhs.gov
Nada.Hanafi@veranexsolutions.com
brittany.jones@resmed.com
csparks@appliedvr.io
Marquez.celine@gene.com